The objective of this study was to determine the effect of different durations of n-3 supplementation during the peripartal period on production and reproduction performance of Holstein dairy cows. Thirty-two Holstein dry cows (16 multiparous and 16 primiparous) were blocked within parity for similar expected calving dates 8 wk before calving. Cows within blocks were assigned randomly to 1 of 4 treatments: (1) control without n-3 fatty acid (FA) supplementation during the dry period; (2) n-3 FA supplementation during the whole dry period (8 wk); and (3) n-3 FA supplementation during the early dry period (first 5 wk; far-off), or (4) n-3 FA supplementation during the late dry period (last 3 wk; close-up). All cows received the same diet without n-3 FA after calving for the first 6 wk of lactation. Ovaries of each cow were examined 10, 17, 24, and 34 d from calving (calving=d 0) by transrectal ultrasonography to determine follicular development. Blood samples were collected at 14-d intervals starting on the first day of the dry period (8 wk before expected calving) to determine plasma concentrations of glucose, β-hydroxybutyrate, nonesterified fatty acids, urea N, aspartate aminotransferase, and insulin. Blood samples were also collected on d 1, 10, 17, 24, 31, and 38 postpartum for determination of progesterone concentration. Milk yield was recorded daily throughout the experiment and samples were taken twice weekly (Monday and Thursday mornings) for analysis of fat, protein, and lactose. Yields of milk and 4% fat-corrected milk and milk composition were similar among treatments except for fat proportion, which tended to be lower in cows that were fed n-3 FA throughout the dry period. We observed no differences among treatments for plasma concentrations of metabolites and hormones. The cows that were fed in the 3 n-3 FA treatments had larger ovulatory follicles compared with those fed the controlled diet. Treatments did not differ significantly in terms of the number of days open, day to first service, or number of services per pregnancy. In conclusion, n-3 FA supplementation throughout the dry period or in the early or late prepartal period had no carryover reproductive postpartum benefits and no effect on the production of Holstein dairy cows.
The objective of this study was to assess the efficacy of a single injection of Prostaglandin F2α (PGF2α) combined with or without GnRH before initiation of a Heatsynch protocol (GnRH-7d-PGF2α-2d-EB-1d-AI) on ovarian response and fertility in lactating Holstein cows. A total of 252 cows with a corpus luteum (CL; ≥10 mm) were assigned to one of three synchronization groups; 1 -Control (n=84), cows received two injections of PGF2α 14 days apart; 2 -Heatsynch with GnRH (PGH, n=88) the cows received PGF2α followed by GnRH four days later and then a Heatsynch protocol was initiated eight days after GnRH treatment; and 3 -Heatsynch without GnRH (PH, n=80) cows received a single injection of PGF2α followed by a Heatsynch protocol initiated 12 days after PGF2α. Cows detected in estrus were inseminated approximately 12 h after onset of estrus. Ovarian response and pregnancy diagnosis were determined by ultrasonography during the synchronization protocol and 30 days after AI, respectively. Results showed the percentage of cows with plasma P4≤0.4 ng/mL at AI were greater in PGH group compared to other groups (90.3 vs. 75.0%, P=0.03). The percentage of cows that ovulated in response to the GnRH injection of Heatsynch was affected (P<0.01) by synchronization protocol, because PGH cows were more likely to ovulate (77.2%) than PH (56.0%) cows. The proportion of cows displaying estrus was greater in PGH (70.4%) and PH (72.5%) groups compared with control (47.0%, P=0.04). Percentage of cows pregnant at 30 days after AI was (P=0.01) affected by synchronization treatment and was greater in PGH (45.16%) compared to control (25.0%) and PH (34.48%) groups. In summary, a short presynchronization that includes an injection of PGF2α and four days later GnRH increased fertility in Holstein cows subjected to a Heatsynch protocol. The enhanced fertility was due to a greater ovulatory response to GnRH of Heatsynch, more adequate plasma P4 concentrations during follicle development and a greater luteal regression following PGF2α prior to AI.
The aim of the present study was to investigate the effects of a PGF 2α analogue (Dinoprost) on involution of the puerperal uterus, especially with pyometra during 35 to 45 days postpartum in multiparous high yielding Holstein dairy cows. At days 40 ± 5 postpartum, 1250 cows were ultrasonographically examined. Fifty cows were diagnosed as pyometric. Fifty pyometric and 50 clinically healthy cows were assigned randomly to one of four groups. Groups were: 1.) Pyometric+Dinoprost cows (PD, n = 25 treated with 25 mg of Dinoprost), 2.) Pyometric+Saline cows (PS, n = 25 treated with saline), 3.) Healthy+Dinoprost cows (HD, n = 25 treated with 25 mg of Dinoprost), and 4.) Healthy+Saline cows (HS, n = 25 treated with saline). All treatments were given intramuscularly. Ultrasonography was performed at the time of examination and 7 days later to evaluate changes in uterine diameter. Treatment with Dinoprost significantly reduced gross uterine diameter in PD in comparison to the PS group in the presence or absence (P4 concentrations <1 ng/ml) of an active corpus luteum. Dinoprost treatment did not decrease gross uterine diameter in groups HD and HS. Luminal diameter was significantly smaller in the PD than in the PS group. Pregnancy rate of PD was greater than PS cows (36% vs 20%, respectively). Days to first service (110 d vs. 140 d) and open days (160 d vs. 190 d) were shorter in PD cows than PS cows. It was concluded that injection of 25 mg of Dinoprost to pyometric cows had uterotonic effects in presence or absence of functional corpus luteum. Therefore, this treatment can help uterine involution in puerperal dairy cows affected by pyometra and consequently improved reproductive performance.
Congenital malformations occur sporadically in cattle; however, congenital structural and functional disorders of the nervous system are rather common in ruminants. Among the numerous causes of congenital nervous system defects, infectious agents are highlighted in this paper. Virus-induced congenital malformations are well known, among which those caused by bovine viral diarrhoea virus (BVDV), Akabane virus (AKAV), Schmallenberg virus (SBV), Bluetongue virus (BTV), and Aino virus (AV) are the most studied. In this study, we specify and categorise macroscopic and histopathological lesions in the brain of 42 newborn calves suffering from severe neurologic signs and diagnosed with BVDV and AKAV infection. Following a complete necropsy, specimens were collected from the brains to track the presence of BVDV, AKAV and SBV utilising reverse transcription polymerase chain reaction. Of the 42 examined calves, 21 were BVDV positive and 6 were AKAV positive, while 15 brains were negative for the studied agents. Regardless of the aetiology, cerebellar hypoplasia, hydranencephaly, hydrocephalus, porencephaly, and microencephaly were detected. Cerebellar hypoplasia was the most common lesion seen in both BVDV-positive and AKAV-positive cases. Virus-induced necrosis of the germinative cells of the external granular layer of cerebellum, as well as vascular damages, are believed to be the underlying causes of cerebellar hypoplasia. BVDV was the most important aetiological agent of such cases in this study.
The occurrence of several pandemics in recent decades has posed a significant threat to human and animal health. The COVID-19 pandemic, which rapidly spread to 187 countries, has caused significant economic disruption in various industries, including the dairy industry. The dairy industry has been affected by supply chain disruptions, consumer behavior changes, and global demand shifts due to the pandemic. The present review aims to evaluate the impact of the COVID-19 pandemic, mainly from the dairy farm level, and propose strategies for mitigating the effects of future global crisis events. The dairy industry, a major source of income for many dairy herds, was significantly impacted by the COVID-19 pandemic. The consumption patterns of milk and dairy products underwent substantial alterations, leading to decreased profitability of dairy farms due to disruptions in the supply chain, increased transportation costs resulting from transportation restrictions, and a shift in consumer purchasing behavior. These factors collectively resulted in reduced revenue from selling milk and dairy products. Heifer replacement considerations also impacted the economic viability of dairy farms. The pandemic caused a shortage of meat (beef, pork, poultry) and a surplus of milk. In addition to the abovementioned factors, the COVID-19 pandemic also impacted other economic indicators, such as gross returns from the sale of culled dairy animals and dairy feed costs. These impacts further amplified the financial challenges faced by the dairy industry and dairy farmers, underscoring the need for robust mitigation strategies and resilient policies to minimize the economic impact of pandemics and other crises. In conclusion, the COVID-19 pandemic has profoundly impacted the dairy industry, affecting supply chains and international commerce. Governments are encouraged to implement measures to mitigate the impact of future pandemics on the dairy sector. The authors of this review propose several recommendations for dairy farmers and veterinarians to increase their resilience in the face of future outbreaks. These recommendations include sourcing feed from reliable local farms, acquiring internet connectivity equipment to facilitate communication during travel restrictions, maintaining a sufficient supply of personal protective equipment, incorporating mechanization in farm operations, stockpiling essential veterinary medications and vaccines, and training technicians to perform veterinary procedures in emergencies when veterinary services are unavailable.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.